Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.
Veronica MollicaMatteo SantoniMarc R MatranaUmberto BassoUgo De GiorgiAlessandro RizzoMarco MaruzzoAndrea MarchettiMatteo RoselliniSara BleveDiana MaslovKarine TawagiErnest PhilonZoe BlakeFrancesco MassariPublished in: Targeted oncology (2021)
In patients with RCC, concomitant PPI use did not seem to affect survival outcomes on ICIs, either as combination therapy or monotherapy.